| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Bicara Therapeutics Inc.
13G/A
BCAX · 055477103
|
4.8% |
5/8/2026
Event 3/31/2026
|
||||
| Red Tree GP, LLC | 4.8% | |||||
| Red Tree Venture Fund, L.P. | 4.8% | |||||
| Heath Lukatch | 4.8% | |||||
|
CeriBell, Inc.
13G
CBLL · 15678C102
|
6.2% |
2/14/2025
Event 12/31/2024
|
||||
| Red Tree GP, LLC | 6.2% | |||||
| Red Tree Venture Fund, L.P. | 5.7% | |||||
| Red Tree Venture Fund SPV II, LLC | 0.5% | |||||
| Heath Lukatch | 6.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.